Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-12-02

Clinical Trial Update: Improving Nutritional Status With Oral Nutritional Supplement in Chinese Elderly [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating an Abbott Nutrition oral nutritional supplement to improve nutritional status in Chinese elderly participants was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abbott Nutrition Oral Nutritional Supplement (Oral nutritional supplement)

Snippet

Sponsor: Abbott Nutrition | Conditions: Malnutrition | Phase 4 | Status: WITHDRAWN